VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4939-2917-7_1PMID 26285742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Follow-Up Assessment of a Phase 1 Trial of Angiogenic Gene Therapy Using Direct Intramyocardial Administration of an Adenoviral Vector Expressing the VEGF121 cDNA for the Treatment of Diffuse Coronary Artery Disease

  2013cited by this paper
• Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab

  2012cited by this paper
• The spliceosome as a target of novel antitumour drugs

  2012cited by this paper
• VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.

  2012cited by this paper
• Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale

  2012cited by this paper
• Role of the VEGF/VEGFR axis in cancer biology and therapy.

  2012cited by this paper
• The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE.

  2011cited by this paper
• WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.

  2011cited by this paper
• Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

  2011cited by this paper
• Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

  2011cited by this paper
• Impaired vascular permeability regulation caused by the VEGF165b splice variant in pre‐eclampsia

  2011cited by this paper
• Serine‐arginine protein kinases: a small protein kinase family with a large cellular presence

  2011cited by this paper
• Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis.

  2011cited by this paper
• SRSF2 is required for sodium butyrate-mediated p21WAF1 induction and premature senescence in human lung carcinoma cell lines

  2011cited by this paper
• Pazopanib for the treatment of renal cancer

  2011cited by this paper
• Adenoviral Delivery of VEGF121 Early in Pregnancy Prevents Spontaneous Development of Preeclampsia in BPH/5 Mice

  2011cited by this paper
• Phosphorylation mechanism and structure of serine‐arginine protein kinases

  2011cited by this paper
• Recombinant human VEGF165b inhibits experimental choroidal neovascularization.

  2010cited by this paper
• VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A

  2010cited by this paper
• Regulation and differential role of the tissue factor isoforms in cardiovascular biology.

  2010cited by this paper
• Multifaceted role of vascular endothelial growth factor signaling in adult tissue physiology: an emerging concept with clinical implications

  2010cited by this paper
• VEGF inhibitors for the treatment of neovascular age-related macular degeneration

  2009cited by this paper
• Molecular Diversity of VEGF‐A as a Regulator of Its Biological Activity

  2009cited by this paper
• SR proteins in vertical integration of gene expression from transcription to RNA processing to translation.

  2009cited by this paper
• VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo

  2009cited by this paper
• Intradermal Delivery of Plasmid VEGF165 by Electroporation Promotes Wound Healing.

  2009cited by this paper
• Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.

  2009cited by this paper
• Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens

  2009cited by this paper
• Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration

  2009cited by this paper
• Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

  2009cited by this paper
• The anti-angiogenic isoforms of VEGF in health and disease.

  2009cited by this paper
• Neutralization of Vascular Endothelial Growth Factor Antiangiogenic Isoforms Is More Effective Than Treatment with Proangiogenic Isoforms in Stimulating Vascular Development and Follicle Progression in the Perinatal Rat Ovary1

  2009cited by this paper
• Liposome-based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischaemic limb disease

  2008cited by this paper
• Recombinant human VEGF165b protein is an effective anti-cancer agent in mice.

  2008cited by this paper
• Mechanical signals modulated vascular endothelial growth factor-A (VEGF-A) alternative splicing in osteoblastic cells through actin polymerisation.

  2008cited by this paper
• Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

  2008cited by this paper
• Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1.

  2008cited by this paper
• Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes.

  2008cited by this paper
• VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

  2008cited by this paper
• Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b

  2008cited by this paper
• VEGF Gene Therapy Augments Localized Angiogenesis and Promotes Anastomotic Wound Healing: A Pilot Study in a Clinically Relevant Animal Model

  2008cited by this paper
• The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

  2008cited by this paper
• VEGF121 promotes lymphangiogenesis in the sentinel lymph nodes of non-small cell lung carcinoma patients.

  2008cited by this paper
• Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction.

  2008cited by this paper
• Treatment of neovascular age-related macular degeneration with pegaptanib and boosting with bevacizumab or ranibizumab as needed.

  2008cited by this paper
• Sustained (rh)VEGF165 release from a sprayed fibrin biomatrix induces angiogenesis, up‐regulation of endogenous VEGF‐R2, and reduces ischemic flap necrosis

  2008cited by this paper
• Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease.

  2008cited by this paper
• Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels.

  2008cited by this paper
• The Alternatively Spliced Anti-Angiogenic Family of VEGF Isoforms VEGFxxxb in Human Kidney Development

  2008cited by this paper
• Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

  2008cited by this paper
• Levels of vascular endothelial growth factor-A165b (VEGF-A165b) are elevated in experimental glaucoma

  2008cited by this paper
• Age-dependent expression of VEGF isoforms and receptors in the rabbit anterior cruciate ligament.

  2007cited by this paper
• Therapeutic Arteriogenesis by Ultrasound-Mediated VEGF165 Plasmid Gene Delivery to Chronically Ischemic Skeletal Muscle

  2007cited by this paper
• Increased expression of VEGF121/VEGF165–189 ratio results in a significant enhancement of human prostate tumor angiogenesis

  2007cited by this paper
• Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

  2007cited by this paper
• Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.

  2007cited by this paper
• Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma

  2007cited by this paper
• Experience with bevacizumab in the management of epithelial ovarian cancer.

  2007cited by this paper
• Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm.

  2007cited by this paper
• Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

  2007cited by this paper
• VEGF in biological control

  2007cited by this paper
• Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia

  2007cited by this paper
• Structure of a VEGF–VEGF receptor complex determined by electron microscopy

  2007cited by this paper
• Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.

  2007cited by this paper
• Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.

  2007cited by this paper
• Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents

  2007cited by this paper
• The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.

  2006cited by this paper
• Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

  2006cited by this paper
• Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.

  2006cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2

  2006cited by this paper
• Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.

  2006cited by this paper
• VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice.

  2006cited by this paper
• Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia.

  2005cited by this paper
• Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes.

  2005cited by this paper
• Nuclear localization of long-VEGF is associated with hypoxia and tumor angiogenesis.

  2005cited by this paper
• Vascular endothelial growth factor plays more than an angiogenic role in the female reproductive system.

  2005cited by this paper
• Understanding alternative splicing: towards a cellular code

  2005cited by this paper
• Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor

  2005cited by this paper
• Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors.

  2005cited by this paper
• Generation of transgenic mice with mild and severe retinal neovascularisation

  2005cited by this paper
• VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.

  2005cited by this paper
• Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales

  2005cited by this paper
• The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

  2005cited by this paper
• SRprises along a messenger's journey.

  2005cited by this paper
• Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes.

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology.

  2004cited by this paper
• Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia.

  2004cited by this paper
• Serum VEGF levels in women with a benign breast tumor or breast cancer

  2004cited by this paper
• Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival.

  2004cited by this paper
• VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant

  2004cited by this paper
• Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.

  2004cited by this paper
• Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein.

  2004cited by this paper
• Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation

  2003cited by this paper
• Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.

  2002cited by this paper
• SRp30c Is a Repressor of 3′ Splice Site Utilization

  2002cited by this paper
• VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

  2002cited by this paper
• Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.

  2002cited by this paper
• Predictive Identification of Exonic Splicing Enhancers in Human Genes

  2002cited by this paper

• Masterful macrophages: understanding and targeting activation dysfunction in diabetic wounds

  2025cites this paper
• Electrochemical sensor for vascular endothelial growth factor based on self-assembling DNA aptamer structure.

  2024cites this paper
• Soluble FLT-1 in angiogenesis: pathophysiological roles and therapeutic implications

  2024cites this paper
• A Splice Form of VEGF, a Potential Anti-Angiogenetic Form of Head and Neck Squamous Cell Cancer Inhibition

  2024cites this paper
• Development and disease-specific regulation of RNA splicing in cardiovascular system

  2024cites this paper
• A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma

  2023cites this paper
• VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases

  2023cites this paper
• Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic Factor

  2022influential citation
• Cytokine profiling in patients with polypoidal choroidal vasculopathy before and after intravitreal injection of ranibizumab.

  2022influential citation
• SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances

  2022cites this paper
• Aerobic‐interval exercise with blood flow restriction potentiates early markers of metabolic health in man

  2022cites this paper
• Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study

  2021cites this paper
• Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization

  2021cites this paper
• VEGF-A splice variants bind VEGFRs with differential affinities

  2020cites this paper
• Debunking the Myth of the Endogenous Antiangiogenic Vegfaxxxb Transcripts.

  2020cites this paper
• Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs

  2020cites this paper
• Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral Microenvironment

  2020cites this paper
• RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target

  2020cites this paper
• Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis

  2020cites this paper
• Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy

  2020cites this paper
• Von Hippel-Lindau Syndrome: Characterization of a Potentially Novel VEGF-A Isoform and Elucidation of Molecular and Vascular Mechanisms of Observed Phenotypic Changes

  2020cites this paper
• Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis

  2019cites this paper
• Genetic Manipulation/Modulation for Target Discovery and Validation

  2019cites this paper
• Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma

  2019cites this paper
• INVESTIGATING THE MOLECULAR REGULATION OF ANGIOGENESIS IN THE HEART

  2019cites this paper
• Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.

  2019cites this paper
• Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2

  2018influential citation
• Anti-angiogenic VEGFAxxxb transcripts are not expressed in the medio-basal hypothalamus of the seasonal sheep

  2018cites this paper
• Factores anti-angiogénicos y preeclampsia

  2018cites this paper
• Pro-angiogenic peptides in biomedicine.

  2018cites this paper
• Role of alternative splicing of VEGF-A in the development of atherosclerosis

  2018cites this paper
• High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment

  2018cites this paper
• KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer

  2017cites this paper
• Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients

  2017cites this paper
• Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options.

  2017cites this paper
• Emerging treatments for age-related macular degeneration

  2017cites this paper
• Analyse de l’épissage alternatif dans les données RNAseq : développement et comparaison d’outils bioinformatiques

  2016cites this paper
• Therapeutic strategies for retinopathy of prematurity

  2015cites this paper